Market overview
The global syringe market is worth USD 21.2 bn in 2026 and is forecast to reach USD 39.8 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Conventional disposable is the largest by product segment.
| Scope | Hypodermic and prefilled syringes used to inject medicines and vaccines: conventional disposable, safety, prefilled glass and plastic, and reusable specialty syringes. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 20.0 bn |
| Value 2026 | USD 21.2 bn |
| Value 2036 | USD 39.8 bn |
| CAGR 2026-2036 | 6.5% |
| Volume 2026 | 47,463 million units |
| Volume 2036 | 84,759 million units |
| Average price 2026 | USD 0.45 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Syringe market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 21.2 bn |
| 2027 | USD 22.6 bn |
| 2028 | USD 24.0 bn |
| 2029 | USD 25.6 bn |
| 2030 | USD 27.3 bn |
| 2031 | USD 29.0 bn |
| 2032 | USD 30.9 bn |
| 2033 | USD 32.9 bn |
| 2034 | USD 35.1 bn |
| 2035 | USD 37.4 bn |
| 2036 | USD 39.8 bn |
Syringe market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Conventional disposable | 40.0% | 29.6% | USD 8.5 bn | 3.3% |
| Safety syringes | 20.0% | 22.6% | USD 4.2 bn | 7.8% |
| Prefilled syringes | 30.0% | 40.8% | USD 6.4 bn | 9.8% |
| Reusable and specialty | 10.0% | 7.0% | USD 2.1 bn | 2.8% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Vaccination | 22.0% | 21.0% | USD 4.7 bn | 6.0% |
| Insulin and diabetes | 14.0% | 14.7% | USD 3.0 bn | 7.0% |
| Biologic and therapeutic injection | 28.0% | 35.3% | USD 5.9 bn | 9.0% |
| Dental and aesthetic | 8.0% | 6.9% | USD 1.7 bn | 5.0% |
| General medication | 28.0% | 22.1% | USD 5.9 bn | 4.0% |
By size
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Up to 3 ml | 56.0% | 55.0% | USD 11.9 bn | 6.3% |
| 5 to 10 ml | 30.0% | 30.0% | USD 6.4 bn | 6.5% |
| Above 10 ml | 14.0% | 15.0% | USD 3.0 bn | 7.2% |
By material
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Polypropylene | 76.0% | 73.0% | USD 16.1 bn | 6.1% |
| Other plastics | 12.0% | 12.0% | USD 2.5 bn | 6.5% |
| Glass | 12.0% | 15.0% | USD 2.5 bn | 8.9% |
By buyer
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 44.0% | 42.0% | USD 9.3 bn | 6.0% |
| Mass vaccination | 22.0% | 22.0% | USD 4.7 bn | 6.5% |
| Clinics and pharmacies | 20.0% | 22.0% | USD 4.2 bn | 7.5% |
| Home | 14.0% | 14.0% | USD 3.0 bn | 6.5% |
Top 25 countries for syringe by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 69.5% of 2026 revenue and the 25 countries below together hold 90.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 5.1 bn | 24.0% | USD 8.8 bn | 5.6% |
| 2 | China | USD 3.0 bn | 14.0% | USD 6.5 bn | 8.1% |
| 3 | India | USD 1.5 bn | 7.0% | USD 3.5 bn | 9.1% |
| 4 | Japan | USD 1.1 bn | 5.0% | USD 1.6 bn | 4.2% |
| 5 | Germany | USD 1.1 bn | 5.0% | USD 1.8 bn | 5.2% |
| 6 | Brazil | USD 742 mn | 3.5% | USD 1.4 bn | 6.5% |
| 7 | France | USD 742 mn | 3.5% | USD 1.2 bn | 5.2% |
| 8 | United Kingdom | USD 636 mn | 3.0% | USD 1.0 bn | 5.0% |
| 9 | Italy | USD 530 mn | 2.5% | USD 836 mn | 4.7% |
| 10 | Indonesia | USD 424 mn | 2.0% | USD 915 mn | 8.0% |
| 11 | Mexico | USD 411 mn | 1.9% | USD 772 mn | 6.5% |
| 12 | Spain | USD 411 mn | 1.9% | USD 772 mn | 6.5% |
| 13 | Russia | USD 411 mn | 1.9% | USD 772 mn | 6.5% |
| 14 | Turkey | USD 411 mn | 1.9% | USD 772 mn | 6.5% |
| 15 | Pakistan | USD 409 mn | 1.9% | USD 772 mn | 6.6% |
| 16 | Poland | USD 356 mn | 1.7% | USD 764 mn | 7.9% |
| 17 | Saudi Arabia | USD 318 mn | 1.5% | USD 680 mn | 7.9% |
| 18 | Egypt | USD 286 mn | 1.4% | USD 617 mn | 8.0% |
| 19 | Thailand | USD 263 mn | 1.2% | USD 565 mn | 8.0% |
| 20 | Argentina | USD 244 mn | 1.1% | USD 521 mn | 7.9% |
| 21 | Canada | USD 227 mn | 1.1% | USD 342 mn | 4.2% |
| 22 | Vietnam | USD 212 mn | 1.0% | USD 454 mn | 7.9% |
| 23 | Bangladesh | USD 199 mn | 0.9% | USD 430 mn | 8.0% |
| 24 | Netherlands | USD 189 mn | 0.9% | USD 287 mn | 4.3% |
| 25 | Chile | USD 180 mn | 0.8% | USD 306 mn | 5.5% |
| Rest of world | USD 1.9 bn | 9.1% | USD 3.4 bn | 5.9% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- BD
- Terumo
- Nipro
- B. Braun
- Gerresheimer
- SCHOTT Pharma
- Cardinal Health
Group 2: Regional and specialist players
- Retractable Technologies
- Ypsomed
- Weigao
- Hindustan Syringes & Medical Devices
- Stevanato Group
- Zhejiang Kindly Medical Devices
- Poly Medicure
- HTL-Strefa
- Medefil
- Henke-Sass Wolf
Group 3: Emerging and niche players
- Sol-Millennium
- UltiMed
- Narang Medical
- Jiangxi Hongda Medical Equipment
- Advin Health Care
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the syringe market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.
The market is divided by product, by application, by size, by material, by buyer. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the syringe market?
The global syringe market is estimated at USD 20.0 bn in 2025 and USD 21.2 bn in 2026.
How fast will the syringe market grow?
It is forecast to reach USD 39.8 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 18.6 bn.
Which country is the largest market for syringe?
United States is the largest market by revenue at USD 5.1 bn in 2026, 24.0% of the global total. The three largest countries together hold 45.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.1% a year from 2026 to 2036.
Which syringe segment is largest?
In the by product split, Conventional disposable is the largest segment with 40.0% of 2026 revenue.
Who are the leading syringe companies?
Global leaders include BD, Terumo, Nipro, B. Braun.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Pharmaceutical Cold ChainUSD 21.6 bn · 8.0% CAGR
- Biopharmaceutical LogisticsUSD 21.7 bn · 9.0% CAGR
- NanomedicineUSD 20.1 bn · 9.0% CAGR
- Medical BillingUSD 20.0 bn · 11.0% CAGR
- Oral Drug DeliveryUSD 22.6 bn · 7.5% CAGR
- Injectable Drug DeliveryUSD 19.6 bn · 9.0% CAGR
- Pharmaceutical GlassUSD 19.4 bn · 7.2% CAGR
- Nasal Drug DeliveryUSD 19.1 bn · 6.2% CAGR